Android app on Google Play

Achillion Pharmaceuticals (ACHN) Prices 15M Shares at $8.40

February 22, 2013 6:41 AM EST Send to a Friend
Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) priced an underwritten public offering of 15,000,000 shares of its common stock at a price to the public of $8.40 per share. The net proceeds to Achillion from the sale of the shares, after deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $118.5 million. The offering is expected to close on February 27, 2013, subject to customary closing conditions. Citigroup and Leerink Swann LLC are acting as joint book-running managers, and JMP Securities LLC, Piper Jaffray & Co. and Wells Fargo Securities, LLC are acting as co-managers for the offering.




You May Also Be Interested In


Related Categories

Equity Offerings

Related Entities

Piper Jaffray, Citi, JMP Securities, Wells Fargo

Add Your Comment